Application Nr Approved Date Route Status External Links
ANDA091392 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage Diabetic Gastroparesis (Diabetic Gastric Stasis) Metoclopramide Injection (Metoclopramide Hydrochloride, Usp) Is Indicated For The Relief Of Symptoms Associated With Acute And Recurrent Diabetic Gastric Stasis. The Prevention Of Nausea And Vomiting Associated With Emetogenic Cancer Chemotherapy Metoclopramide Injection Is Indicated For The Prophylaxis Of Vomiting Associated With Emetogenic Cancer Chemotherapy. The Prevention Of Postoperative Nausea And Vomiting Metoclopramide Injection Is Indicated For The Prophylaxis Of Postoperative Nausea And Vomiting In Those Circumstances Where Nasogastric Suction Is Undesirable. Small Bowel Intubation Metoclopramide Injection May Be Used To Facilitate Small Bowel Intubation In Adults And Pediatric Patients In Whom The Tube Does Not Pass The Pylorus With Conventional Maneuvers. Radiological Examination Metoclopramide Injection May Be Used To Stimulate Gastric Emptying And Intestinal Transit Of Barium In Cases Where Delayed Emptying Interferes With Radiological Examination Of The Stomach And/or Small Intestine.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Metoclopramide Hydrochloride METOCLOPRAMIDE HYDROCHLORIDE ZINC1530716

Comments